{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:58:31Z","timestamp":1769270311501,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020604","name":"Novartis Portugal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020604","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Econ Rev"],"DOI":"10.1186\/s13561-024-00550-2","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T15:02:28Z","timestamp":1726153348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patients\u2019 health care resources utilization and costs estimation across cardiovascular risk categories: insights from the LATINO study"],"prefix":"10.1186","volume":"14","author":[{"given":"Cristina","family":"Gavina","sequence":"first","affiliation":[]},{"given":"Alexandra","family":"Borges","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Afonso-Silva","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Fortuna","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Canelas-Pais","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Amaral","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Seabra","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"given":"Tiago","family":"Taveira-Gomes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"25","key":"550_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular diseases and Risk factors, 1990\u20132019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"550_CR2","doi-asserted-by":"publisher","unstructured":"Jebari-Benslaiman S, Galicia-Garc\u00eda U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K et al. Pathophysiology of Atherosclerosis. Int J Mol Sci. 2022;23(6). https:\/\/doi.org\/10.3390\/ijms23063346","DOI":"10.3390\/ijms23063346"},{"issue":"4","key":"550_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of Atherothrombotic Disease. Circ Res. 2016;118(4):535\u201346.","journal-title":"Circ Res"},{"key":"550_CR4","unstructured":"Global Health Estimates. Life expectancy and leading causes of death and disability. [cited 2023 Apr 7]. https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates"},{"issue":"1","key":"550_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, Regional, and National Burden of Cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"550_CR6","unstructured":"Plano Nacional. de Sa\u00fade 2021\u20132030. PNS 2030. 2019."},{"issue":"34","key":"550_CR7","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337.","journal-title":"Eur Heart J"},{"key":"550_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.atherosclerosis.2022.06.518","volume":"355","author":"F Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo F, Seabra D, Afonso-Silva M, Grangeia D, Taveira-Gomes T, Gavina C. Cardiovascular outcomes according to risk category: results of a retrospective database study. Atherosclerosis. 2022;355:96\u20137.","journal-title":"Atherosclerosis"},{"key":"550_CR9","doi-asserted-by":"publisher","unstructured":"Gavina C, Carvalho DS, Pardal M, Afonso-Silva M, Grangeia D, Dinis-Oliveira RJ et al. Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data. J Clin Med Res. 2022;11(22). https:\/\/doi.org\/10.3390\/jcm11226825","DOI":"10.3390\/jcm11226825"},{"key":"550_CR10","doi-asserted-by":"crossref","unstructured":"Gavina C, Seabra Carvalho D, Afonso-Silva M, Brand\u00e3o Abreu D, Canelas-Pais M, Taveira-Gomes T et al. Long-term cardiovascular outcomes in a population-based multicentric cohort of northern Portugal: Validation of the ESC\/EAS prognostic risk classification. J Clin Lipidol. 2024; https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1933287424000497","DOI":"10.1016\/j.jacl.2024.04.002"},{"issue":"1","key":"550_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12872-019-1231-z","volume":"19","author":"RD Govender","year":"2019","unstructured":"Govender RD, Al-Shamsi S, Soteriades ES, Regmi D. Incidence and risk factors for recurrent cardiovascular disease in middle-eastern adults: a retrospective study. BMC Cardiovasc Disord. 2019;19(1):253.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"550_CR12","doi-asserted-by":"publisher","first-page":"e022198","DOI":"10.1161\/JAHA.121.022198","volume":"11","author":"DL Steen","year":"2022","unstructured":"Steen DL, Khan I, Andrade K, Koumas A, Giugliano RP. Event rates and risk factors for recurrent Cardiovascular events and mortality in a contemporary Post Acute Coronary Syndrome Population representing 239 234 patients during 2005 to 2018 in the United States. J Am Heart Assoc. 2022;11(9):e022198.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"550_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/ehjqcco\/qcy058","volume":"5","author":"M Lindh","year":"2019","unstructured":"Lindh M, Banefelt J, Fox KM, Hallberg S, Tai M-H, Eriksson M, et al. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data. Eur Heart J Qual Care Clin Outcomes. 2019;5(3):225\u201332.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"550_CR14","doi-asserted-by":"crossref","unstructured":"Gliedt JA, Spector AL, Schneider MJ, Williams J, Young S. A Description of Theoretical Models for Health Service Utilization: A Scoping Review of the Literature. Inquiry. 2023;60:469580231176855.","DOI":"10.1177\/00469580231176855"},{"issue":"8","key":"550_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","volume":"123","author":"PA Heidenreich","year":"2011","unstructured":"Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of Cardiovascular Disease in the United States. Circulation. 2011;123(8):933\u201344.","journal-title":"Circulation"},{"issue":"8","key":"550_CR16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","volume":"43","author":"A Timmis","year":"2022","unstructured":"Timmis A, Vardas P, Townsend N, Torbica A, Katus H, Smedt D, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43(8):716\u201399.","journal-title":"Eur Heart J"},{"issue":"8","key":"550_CR17","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2022 update: a Report from the American Heart Association. Circulation. 2022;145(8):e153\u2013639.","journal-title":"Circulation"},{"key":"550_CR18","unstructured":"CVD statistics. [cited 2023 May 15]. https:\/\/www.ehnheart.org\/cvd-statistics.html"},{"issue":"6","key":"550_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.repc.2020.08.007","volume":"40","author":"J Costa","year":"2021","unstructured":"Costa J, Alarc\u00e3o J, Amaral-Silva A, Ara\u00fajo F, Ascen\u00e7\u00e3o R, Caldeira D, et al. Atherosclerosis: the cost of illness in Portugal. Rev Port Cardiol. 2021;40(6):409\u201319.","journal-title":"Rev Port Cardiol"},{"issue":"7","key":"550_CR20","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/dom.14698","volume":"24","author":"A Norhammar","year":"2022","unstructured":"Norhammar A, Bodegard J, Eriksson JW, Haller H, Linssen GCM, Banerjee A, et al. Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: a multinational, observational study across 12 countries. Diabetes Obes Metab. 2022;24(7):1277\u201387.","journal-title":"Diabetes Obes Metab"},{"key":"550_CR21","doi-asserted-by":"publisher","first-page":"100438","DOI":"10.1016\/j.lanepe.2022.100438","volume":"20","author":"J Sundstr\u00f6m","year":"2022","unstructured":"Sundstr\u00f6m J, Bodegard J, Bollmann A, Vervloet MG, Mark PB, Karasik A, et al. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2\u00b74 million patients from 11 countries: the CaReMe CKD study. Lancet Reg Health Eur. 2022;20:100438.","journal-title":"Lancet Reg Health Eur"},{"issue":"18","key":"550_CR22","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.116.026252","volume":"135","author":"NB Allen","year":"2017","unstructured":"Allen NB, Zhao L, Liu L, Daviglus M, Liu K, Fries J, et al. Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare costs: forty-year Follow-Up of the CHA Study (Chicago Heart Association Detection Project in Industry). Circulation. 2017;135(18):1693\u2013701.","journal-title":"Circulation"},{"issue":"10","key":"550_CR23","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.jacc.2017.12.064","volume":"71","author":"LJ Shaw","year":"2018","unstructured":"Shaw LJ, Goyal A, Mehta C, Xie J, Phillips L, Kelkar A, et al. 10-Year resource utilization and costs for Cardiovascular Care. J Am Coll Cardiol. 2018;71(10):1078\u201389.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"550_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s41669-021-00257-8","volume":"5","author":"DT Tran","year":"2021","unstructured":"Tran DT, Palfrey D, Welsh R. The Healthcare Cost Burden in adults with high risk for Cardiovascular Disease. Pharmacoecon Open. 2021;5(3):425\u201335.","journal-title":"Pharmacoecon Open"},{"key":"550_CR25","unstructured":"ACSS. Operacionaliza\u00e7\u00e3o da Contratualiza\u00e7\u00e3o nos Cuidados de Sa\u00fade Prim\u00e1rios para 2019. [cited 2024 Aug 14]. http:\/\/accsinternet-qua2.azurewebsites.net\/wp-content\/uploads\/2019\/02\/20190214_Operacionalizacao_CSP_2019_vf.pdf"},{"key":"550_CR26","unstructured":"Portaria no 163\/2013. Di\u00e1rio da Rep\u00fablica: I S\u00e9rie, n.o 80. https:\/\/files.dre.pt\/1s\/2013\/04\/08000\/0249502606.pdf"},{"key":"550_CR27","unstructured":"Portaria no 20\/2014. Di\u00e1rio da Rep\u00fablica, 1.a s\u00e9rie \u2013 N.o 20. https:\/\/www.acss.min-saude.pt\/wp-content\/uploads\/2016\/12\/Portaria_20_2014-1.pdf"},{"key":"550_CR28","unstructured":"Portaria no 234\/2015. Di\u00e1rio da Rep\u00fablica, 1.a s\u00e9rie \u2014 N.o 153. https:\/\/files.diariodarepublica.pt\/1s\/2015\/08\/15300\/0551605654.pdf"},{"key":"550_CR29","unstructured":"Portaria no 207\/2017. Di\u00e1rio da Rep\u00fablica, 1.a s\u00e9rie \u2014 N.o 132. https:\/\/www.ers.pt\/uploads\/writer_file\/document\/2141\/Portaria207_17.pdf"},{"key":"550_CR30","unstructured":"Portaria no 254\/2018. Di\u00e1rio da Rep\u00fablica, 1.a s\u00e9rie \u2014 N.o 173. https:\/\/files.dre.pt\/gratuitos\/1s\/2018\/09\/17300.pdf"},{"key":"550_CR31","unstructured":"ACSS. Termos de Refer\u00eancia para contratualiza\u00e7\u00e3o de cuidados de sa\u00fade no SNS 2023. 2022."},{"issue":"1","key":"550_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12872-023-03518-y","volume":"23","author":"K Steen Carlsson","year":"2023","unstructured":"Steen Carlsson K, Nilsson K, Wolden ML, Faurby M. Economic burden of atherosclerotic cardiovascular disease: a matched case-control study in more than 450,000 Swedish individuals. BMC Cardiovasc Disord. 2023;23(1):483.","journal-title":"BMC Cardiovasc Disord"},{"key":"550_CR33","unstructured":"Current health expenditure per capita (current US$.) - World. World Bank Open Data. [cited 2024 Jul 23]. https:\/\/data.worldbank.org\/indicator\/SH.XPD.CHEX.PC.CD?locations=1W&skipRedirection=true&view=map"},{"issue":"23","key":"550_CR34","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","volume":"375","author":"RE Sherman","year":"2016","unstructured":"Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world evidence - what is it and what can it tell us? N Engl J Med. 2016;375(23):2293\u20137.","journal-title":"N Engl J Med"}],"container-title":["Health Economics Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-024-00550-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13561-024-00550-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-024-00550-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T15:05:08Z","timestamp":1726153508000},"score":1,"resource":{"primary":{"URL":"https:\/\/healtheconomicsreview.biomedcentral.com\/articles\/10.1186\/s13561-024-00550-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1186\/s13561-024-00550-2","relation":{},"ISSN":["2191-1991"],"issn-type":[{"value":"2191-1991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The database use was authorized by the Ethical Committee and Data Protection Officer of ULSM (translated from <i>Comiss\u00e3o de \u00c9tica para a Sa\u00fade da Unidade Local de Sa\u00fade de Matosinhos<\/i>) under approval codes N.\u00ba21\/CE\/JAS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MAS and IC are employees at Novartis Portugal. All other authors have no conflicts of interest related to this manuscript to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}